These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 33802591

  • 1. PGC1α Promotes Cisplatin Resistance in Ovarian Cancer by Regulating the HSP70/HK2/VDAC1 Signaling Pathway.
    Li Y, Kang J, Fu J, Luo H, Liu Y, Li Y, Sun L.
    Int J Mol Sci; 2021 Mar 03; 22(5):. PubMed ID: 33802591
    [Abstract] [Full Text] [Related]

  • 2. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback.
    Shen L, Zhou L, Xia M, Lin N, Ma J, Dong D, Sun L.
    Exp Cell Res; 2021 Jan 01; 398(1):112369. PubMed ID: 33220258
    [Abstract] [Full Text] [Related]

  • 3. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
    Zhang XY, Zhang M, Cong Q, Zhang MX, Zhang MY, Lu YY, Xu CJ.
    Int J Biochem Cell Biol; 2018 Feb 01; 95():9-16. PubMed ID: 29247711
    [Abstract] [Full Text] [Related]

  • 4. PGC1α promotes cisplatin resistance in human ovarian carcinoma cells through upregulation of mitochondrial biogenesis.
    Shen L, Sun B, Sheng J, Yu S, Li Y, Xu H, Su J, Sun L.
    Int J Oncol; 2018 Jul 01; 53(1):404-416. PubMed ID: 29749474
    [Abstract] [Full Text] [Related]

  • 5. Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells.
    Yang X, Wang J, Zhou Y, Wang Y, Wang S, Zhang W.
    Cancer Lett; 2012 Aug 28; 321(2):137-43. PubMed ID: 22281241
    [Abstract] [Full Text] [Related]

  • 6. Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism.
    Zhang M, Liu Q, Zhang M, Cao C, Liu X, Zhang M, Li G, Xu C, Zhang X.
    J Nanobiotechnology; 2020 Nov 07; 18(1):161. PubMed ID: 33160373
    [Abstract] [Full Text] [Related]

  • 7. The Nrf2/PGC1α Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer.
    Deng X, Lin N, Fu J, Xu L, Luo H, Jin Y, Liu Y, Sun L, Su J.
    Oxid Med Cell Longev; 2020 Nov 07; 2020():4830418. PubMed ID: 33294122
    [Abstract] [Full Text] [Related]

  • 8. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V, Ben-Hail D, Admoni L, Krelin Y, Tripathi SS.
    Biochim Biophys Acta; 2015 Oct 07; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [Abstract] [Full Text] [Related]

  • 9. In silico construction of HK2-VDAC1 complex and investigating the HK2 binding-induced molecular gating mechanism of VDAC1.
    Zhang D, Yip YM, Li L.
    Mitochondrion; 2016 Sep 07; 30():222-8. PubMed ID: 27544294
    [Abstract] [Full Text] [Related]

  • 10. Zinc and p53 disrupt mitochondrial binding of HK2 by phosphorylating VDAC1.
    Xue YN, Yu BB, Li JL, Guo R, Zhang LC, Sun LK, Liu YN, Li Y.
    Exp Cell Res; 2019 Jan 01; 374(1):249-258. PubMed ID: 30528266
    [Abstract] [Full Text] [Related]

  • 11. Diallyl trisulfide alleviates chemotherapy sensitivity of ovarian cancer via the AMPK/SIRT1/PGC1α pathway.
    Wang Z, Yan Y, Lou Y, Huang X, Liu L, Weng Z, Cui Y, Wu X, Cai H, Chen X, Ji Y.
    Cancer Sci; 2023 Feb 01; 114(2):357-369. PubMed ID: 36309839
    [Abstract] [Full Text] [Related]

  • 12. Mitochondrial Voltage-Dependent Anion Channel 1-Hexokinase-II Complex-Targeted Strategy for Melanoma Inhibition Using Designed Multiblock Peptide Amphiphiles.
    Zhang F, Angelova A, Garamus VM, Angelov B, Tu S, Kong L, Zhang X, Li N, Zou A.
    ACS Appl Mater Interfaces; 2021 Aug 04; 13(30):35281-35293. PubMed ID: 34309373
    [Abstract] [Full Text] [Related]

  • 13. Euxanthone inhibits glycolysis and triggers mitochondria-mediated apoptosis by targeting hexokinase 2 in epithelial ovarian cancer.
    Zou J, Wang Y, Liu M, Huang X, Zheng W, Gao Q, Wang H.
    Cell Biochem Funct; 2018 Aug 04; 36(6):303-311. PubMed ID: 29984416
    [Abstract] [Full Text] [Related]

  • 14. Knockout of VDAC1 in H9c2 Cells Promotes Oxidative Stress-Induced Cell Apoptosis through Decreased Mitochondrial Hexokinase II Binding and Enhanced Glycolytic Stress.
    Yang M, Sun J, Stowe DF, Tajkhorshid E, Kwok WM, Camara AKS.
    Cell Physiol Biochem; 2020 Sep 09; 54(5):853-874. PubMed ID: 32901466
    [Abstract] [Full Text] [Related]

  • 15. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.
    Prezma T, Shteinfer A, Admoni L, Raviv Z, Sela I, Levi I, Shoshan-Barmatz V.
    Cell Death Dis; 2013 Sep 19; 4(9):e809. PubMed ID: 24052077
    [Abstract] [Full Text] [Related]

  • 16. VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis.
    Ben-Hail D, Shoshan-Barmatz V.
    Biochim Biophys Acta; 2016 Jul 19; 1863(7 Pt A):1612-23. PubMed ID: 27064145
    [Abstract] [Full Text] [Related]

  • 17. Bcl-2 overexpression reduces cisplatin cytotoxicity by decreasing ER-mitochondrial Ca2+ signaling in SKOV3 cells.
    Xu L, Xie Q, Qi L, Wang C, Xu N, Liu W, Yu Y, Li S, Xu Y.
    Oncol Rep; 2018 Mar 19; 39(3):985-992. PubMed ID: 29286126
    [Abstract] [Full Text] [Related]

  • 18. ABT737 enhances ovarian cancer cells sensitivity to cisplatin through regulation of mitochondrial fission via Sirt3 activation.
    Hou L, Wang R, Wei H, Li S, Liu L, Lu X, Yu H, Liu Z.
    Life Sci; 2019 Sep 01; 232():116561. PubMed ID: 31247208
    [Abstract] [Full Text] [Related]

  • 19. p53/PGC‑1α‑mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis.
    Li J, Li Y, Chen L, Yu B, Xue Y, Guo R, Su J, Liu Y, Sun L.
    Mol Med Rep; 2020 Jul 01; 22(1):155-164. PubMed ID: 32377739
    [Abstract] [Full Text] [Related]

  • 20. ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells.
    Xie Q, Su J, Jiao B, Shen L, Ma L, Qu X, Yu C, Jiang X, Xu Y, Sun L.
    Int J Oncol; 2016 Dec 01; 49(6):2507-2519. PubMed ID: 27748803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.